CHINA PHARMA HOLDINGS, INC. Cost of Revenue
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Cost of Revenue of $864.77 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. cost of revenue for the quarter ending 2026-06-30 was $864.77K, a 22.29% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. cost of revenue for the quarter ending 2026-03-31 was $698.05K, a 45.14% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. cost of revenue for the quarter ending 2025-12-31 was $1.08M, a 16.94% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. cost of revenue for the quarter ending 2025-09-30 was $815.87K, a 49.63% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. cost of revenue for fiscal 2025 was $4.28M, a 34.36% decline from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. cost of revenue for fiscal 2024 was $6.51M, a 10.67% decline from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. cost of revenue for fiscal 2023 was $7.29M, a 15.19% decline from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. cost of revenue for fiscal 2022 was $8.60M, a 7.48% decline from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $864.77K 10-Q · filed 2026-08-14 | $1.56M 10-Q · filed 2026-08-14 | $2.64M derived: sum of 3 quarters · filed 2026-08-14 | $3.45M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $698.05K 10-Q · filed 2026-05-15 | $1.77M derived: sum of 2 quarters · filed 2026-05-15 | $2.59M derived: sum of 3 quarters · filed 2026-05-15 | $3.70M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $1.89M derived: sum of 2 quarters · filed 2026-04-01 | $3.00M derived: sum of 3 quarters · filed 2026-08-14 | $4.28M 10-K · filed 2026-04-01 | |||
| 2025-09-30 | $815.87K 10-Q · filed 2025-11-12 | $1.93M derived: sum of 2 quarters · filed 2026-08-14 | $3.20M 10-Q · filed 2025-11-12 | $4.50M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $1.11M 10-Q · filed 2026-08-14 | $2.39M 10-Q · filed 2026-08-14 | $3.68M derived: sum of 3 quarters · filed 2026-08-14 | $5.30M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $1.27M 10-Q · filed 2026-05-15 | $2.57M derived: sum of 2 quarters · filed 2026-05-15 | $4.19M derived: sum of 3 quarters · filed 2026-05-15 | $6.13M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $2.91M derived: sum of 2 quarters · filed 2026-04-01 | $4.85M derived: sum of 3 quarters · filed 2026-04-01 | $6.51M 10-K · filed 2026-04-01 | |||
| 2024-09-30 | $1.62M 10-Q · filed 2025-11-12 | $3.56M derived: sum of 2 quarters · filed 2025-11-12 | $5.22M 10-Q · filed 2025-11-12 | $7.45M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $1.94M 10-Q · filed 2025-08-14 | $3.60M 10-Q · filed 2025-08-14 | $5.83M derived: sum of 3 quarters · filed 2025-08-14 | $7.87M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $1.66M 10-Q · filed 2025-05-14 | $3.89M derived: sum of 2 quarters · filed 2025-05-14 | $5.93M derived: sum of 3 quarters · filed 2025-05-14 | $7.17M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.27M derived: sum of 2 quarters · filed 2025-03-31 | $5.51M derived: sum of 3 quarters · filed 2025-03-31 | $7.29M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $2.04M 10-Q · filed 2024-11-13 | $3.28M derived: sum of 2 quarters · filed 2024-11-13 | $5.06M 10-Q · filed 2024-11-13 | $7.94M derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $1.24M 10-Q · filed 2024-08-14 | $3.03M 10-Q · filed 2024-08-14 | $5.91M derived: sum of 3 quarters · filed 2024-08-14 | $8.01M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $1.78M 10-Q · filed 2023-05-12 | $4.66M derived: sum of 2 quarters · filed 2024-04-01 | $6.76M derived: sum of 3 quarters · filed 2024-04-01 | $8.61M derived: sum of 4 quarters · filed 2024-04-01 | |||
| 2022-12-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $4.98M derived: sum of 2 quarters · filed 2024-04-01 | $6.82M derived: sum of 3 quarters · filed 2024-04-01 | $8.60M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $2.10M 10-Q · filed 2023-11-13 | $3.95M derived: sum of 2 quarters · filed 2023-11-13 | $5.72M 10-Q · filed 2023-11-13 | $8.31M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $1.84M 10-Q · filed 2023-08-14 | $3.62M 10-Q · filed 2023-08-14 | $6.20M derived: sum of 3 quarters · filed 2023-08-14 | $8.48M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $1.77M 10-Q · filed 2023-05-12 | $4.36M derived: sum of 2 quarters · filed 2023-05-12 | $6.64M derived: sum of 3 quarters · filed 2023-05-12 | $8.98M derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $4.86M derived: sum of 2 quarters · filed 2023-03-30 | $7.21M derived: sum of 3 quarters · filed 2023-03-30 | $9.29M 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $2.28M 10-Q · filed 2022-11-14 | $4.62M derived: sum of 2 quarters · filed 2022-11-14 | $6.71M 10-Q · filed 2022-11-14 | $9.07M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $2.34M 10-Q · filed 2022-08-11 | $4.43M 10-Q · filed 2022-08-11 | $6.80M derived: sum of 3 quarters · filed 2022-08-11 | $9.15M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $2.09M 10-Q · filed 2022-05-12 | $4.46M derived: sum of 2 quarters · filed 2022-05-12 | $6.81M derived: sum of 3 quarters · filed 2022-05-12 | $9.43M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $4.72M derived: sum of 2 quarters · filed 2022-03-30 | $7.34M derived: sum of 3 quarters · filed 2022-03-30 | $8.91M 10-K · filed 2022-03-30 | |||
| 2020-09-30 | $2.35M 10-Q · filed 2021-11-12 | $4.97M derived: sum of 2 quarters · filed 2021-11-12 | $6.54M 10-Q · filed 2021-11-12 | $9.30M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $2.62M 10-Q · filed 2021-08-13 | $4.19M 10-Q · filed 2021-08-13 | $6.95M derived: sum of 3 quarters · filed 2021-08-13 | $8.95M derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $1.57M 10-Q · filed 2021-05-14 | $4.33M derived: sum of 2 quarters · filed 2021-05-14 | $6.33M derived: sum of 3 quarters · filed 2021-05-14 | $8.74M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $4.76M derived: sum of 2 quarters · filed 2021-03-26 | $7.17M derived: sum of 3 quarters · filed 2021-03-26 | $9.44M 10-K · filed 2021-03-26 | |||
| 2019-09-30 | $2.00M 10-Q · filed 2020-11-13 | $4.41M derived: sum of 2 quarters · filed 2020-11-13 | $6.68M 10-Q · filed 2020-11-13 | $10.10M derived: sum of 4 quarters · filed 2020-11-13 | |||
| 2019-06-30 | $2.41M 10-Q · filed 2020-08-13 | $4.68M 10-Q · filed 2020-08-13 | $8.09M derived: sum of 3 quarters · filed 2020-08-13 | $9.88M derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | $2.27M 10-Q · filed 2020-05-14 | $5.69M derived: sum of 2 quarters · filed 2020-05-14 | $7.47M derived: sum of 3 quarters · filed 2020-05-14 | $10.07M derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | $3.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $5.20M derived: sum of 2 quarters · filed 2020-03-30 | $7.79M derived: sum of 3 quarters · filed 2020-03-30 | $10.36M 10-K · filed 2020-03-30 | |||
| 2018-09-30 | $1.79M 10-Q · filed 2019-11-14 | $4.38M derived: sum of 2 quarters · filed 2019-11-14 | $6.94M 10-Q · filed 2019-11-14 | $10.11M derived: sum of 4 quarters · filed 2019-11-14 | |||
| 2018-06-30 | $2.59M 10-Q · filed 2019-08-14 | $5.16M 10-Q · filed 2019-08-14 | $8.32M derived: sum of 3 quarters · filed 2019-08-14 | $11.06M derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | $2.56M 10-Q · filed 2019-05-14 | $5.73M derived: sum of 2 quarters · filed 2019-05-14 | $8.47M derived: sum of 3 quarters · filed 2019-05-14 | $10.74M derived: sum of 4 quarters · filed 2019-05-14 | |||
| 2017-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $5.91M derived: sum of 2 quarters · filed 2019-03-28 | $8.18M derived: sum of 3 quarters · filed 2019-03-28 | $10.74M 10-K · filed 2019-03-28 | |||
| 2017-09-30 | $2.74M 10-Q · filed 2018-11-14 | $5.01M derived: sum of 2 quarters · filed 2018-11-14 | $7.58M 10-Q · filed 2018-11-14 | $11.09M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | $2.27M 10-Q · filed 2018-08-14 | $4.84M 10-Q · filed 2018-08-14 | $8.35M derived: sum of 3 quarters · filed 2018-08-14 | $11.13M derived: sum of 4 quarters · filed 2018-08-14 | |||
| 2017-03-31 | $2.57M 10-Q · filed 2018-05-14 | $6.08M derived: sum of 2 quarters · filed 2018-05-14 | $8.86M derived: sum of 3 quarters · filed 2018-05-14 | $11.92M derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $6.29M derived: sum of 2 quarters · filed 2018-04-02 | $9.35M derived: sum of 3 quarters · filed 2018-04-02 | $12.35M 10-K · filed 2018-04-02 | |||
| 2016-09-30 | $2.78M 10-Q · filed 2017-11-14 | $2.70M 10-Q · filed 2016-11-14 | $5.84M derived: sum of 2 quarters · filed 2017-11-14 | $8.84M 10-Q · filed 2017-11-14 | $8.64M 10-Q · filed 2016-11-14 | $11.95M derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | $3.06M 10-Q · filed 2017-08-14 | $2.87M 10-Q · filed 2016-08-11 | $6.06M 10-Q · filed 2017-08-14 | $5.94M 10-Q · filed 2016-08-11 | $9.17M derived: sum of 3 quarters · filed 2017-08-14 | $12.89M derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | $3.00M 10-Q · filed 2017-05-11 | $3.07M 10-Q · filed 2016-05-16 | $6.11M derived: sum of 2 quarters · filed 2017-05-11 | $9.83M derived: sum of 3 quarters · filed 2017-05-11 | $14.34M derived: sum of 4 quarters · filed 2017-05-11 | ||
| 2015-12-31 | $3.11M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $6.83M derived: sum of 2 quarters · filed 2017-03-31 | $11.34M derived: sum of 3 quarters · filed 2017-03-31 | $15.78M 10-K · filed 2017-03-31 | |||
| 2015-09-30 | $3.72M 10-Q · filed 2016-11-14 | $8.23M derived: sum of 2 quarters · filed 2016-11-14 | $12.67M 10-Q · filed 2016-11-14 | $17.67M derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | $4.51M 10-Q · filed 2016-08-11 | $8.95M 10-Q · filed 2016-08-11 | $13.95M derived: sum of 3 quarters · filed 2016-08-11 | $18.00M derived: sum of 4 quarters · filed 2016-08-11 | |||
| 2015-03-31 | $4.43M 10-Q · filed 2016-05-16 | $9.43M derived: sum of 2 quarters · filed 2016-05-16 | $13.49M derived: sum of 3 quarters · filed 2016-05-16 | $17.21M derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $9.06M derived: sum of 2 quarters · filed 2016-03-30 | $12.77M derived: sum of 3 quarters · filed 2016-03-30 | $17.22M 10-K · filed 2016-03-30 | |||
| 2014-09-30 | $4.06M 10-Q · filed 2015-12-28 | $7.77M derived: sum of 2 quarters · filed 2015-12-28 | $12.22M 10-Q · filed 2015-12-28 | $17.78M derived: sum of 4 quarters · filed 2015-12-28 | |||
| 2014-06-30 | $3.71M 10-Q · filed 2015-12-28 | $8.16M 10-Q · filed 2015-12-28 | $13.73M derived: sum of 3 quarters · filed 2015-12-28 | $19.59M derived: sum of 4 quarters · filed 2015-12-28 | |||
| 2014-03-31 | $4.45M 10-Q · filed 2015-12-28 | $10.01M derived: sum of 2 quarters · filed 2015-12-28 | $15.88M derived: sum of 3 quarters · filed 2015-12-28 | $21.73M derived: sum of 4 quarters · filed 2015-12-28 | |||
| 2013-12-31 | $5.57M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-28 | $11.43M derived: sum of 2 quarters · filed 2015-12-28 | $17.28M derived: sum of 3 quarters · filed 2015-12-28 | $23.41M 10-K · filed 2015-12-28 | |||
| 2013-09-30 | $5.86M 10-Q · filed 2014-11-14 | $11.71M derived: sum of 2 quarters · filed 2014-11-14 | $17.84M 10-Q · filed 2014-11-14 | $26.32M derived: sum of 4 quarters · filed 2014-11-14 | |||
| 2013-06-30 | $5.85M 10-Q · filed 2014-08-14 | $11.97M 10-Q · filed 2014-08-14 | $20.46M derived: sum of 3 quarters · filed 2014-08-14 | $29.39M derived: sum of 4 quarters · filed 2014-08-14 | |||
| 2013-03-31 | $6.13M 10-Q · filed 2014-05-15 | $14.61M derived: sum of 2 quarters · filed 2014-05-15 | $23.54M derived: sum of 3 quarters · filed 2014-05-15 | $34.00M derived: sum of 4 quarters · filed 2014-05-15 | |||
| 2012-12-31 | $8.49M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $17.42M derived: sum of 2 quarters · filed 2014-03-20 | $27.88M derived: sum of 3 quarters · filed 2014-03-20 | $38.66M 10-K · filed 2014-03-20 | |||
| 2012-09-30 | $8.93M 10-Q · filed 2013-11-14 | $19.39M derived: sum of 2 quarters · filed 2013-11-14 | $30.17M 10-Q · filed 2013-11-14 | $45.31M derived: sum of 4 quarters · filed 2013-11-14 | |||
| 2012-06-30 | $10.46M 10-Q · filed 2013-08-14 | $21.24M 10-Q · filed 2013-08-14 | $36.38M derived: sum of 3 quarters · filed 2013-08-14 | $49.85M derived: sum of 4 quarters · filed 2013-08-14 | |||
| 2012-03-31 | $10.78M 10-Q · filed 2013-05-14 | $25.92M derived: sum of 2 quarters · filed 2013-05-14 | $39.39M derived: sum of 3 quarters · filed 2013-05-14 | $51.71M derived: sum of 4 quarters · filed 2013-05-14 | |||
| 2011-12-31 | $15.14M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $28.61M derived: sum of 2 quarters · filed 2013-03-14 | $40.93M derived: sum of 3 quarters · filed 2013-03-14 | $52.18M 10-K · filed 2013-03-14 | |||
| 2011-09-30 | $13.47M 10-Q · filed 2012-11-14 | $25.79M derived: sum of 2 quarters · filed 2012-11-14 | $37.04M 10-Q · filed 2012-11-14 | $51.54M derived: sum of 4 quarters · filed 2012-11-14 | |||
| 2011-06-30 | $12.32M 10-Q · filed 2012-08-14 | $23.57M 10-Q · filed 2012-08-14 | $38.06M derived: sum of 3 quarters · filed 2012-08-14 | $49.12M derived: sum of 4 quarters · filed 2012-08-14 | |||
| 2011-03-31 | $11.25M 10-Q · filed 2012-05-14 | $25.74M derived: sum of 2 quarters · filed 2012-05-14 | $36.80M derived: sum of 3 quarters · filed 2012-05-14 | $46.39M derived: sum of 4 quarters · filed 2012-05-14 | |||
| 2010-12-31 | $14.49M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | $25.55M derived: sum of 2 quarters · filed 2012-03-14 | $35.14M derived: sum of 3 quarters · filed 2012-03-14 | $44.11M 10-K · filed 2012-03-14 | |||
| 2010-09-30 | $11.06M 10-Q/A · filed 2012-03-06 | $20.64M derived: sum of 2 quarters · filed 2012-03-06 | $29.61M 10-Q/A · filed 2012-03-06 | ||||
| 2010-06-30 | $9.59M 10-Q/A · filed 2011-09-06 | $18.56M 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |